Location: New York, NY
CIK: 0001609251 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 15, 2023
Total Value: $272M
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 201,222 | $45.45M | 16.7% | $127.97 | +80.0% | — | 91307C102 |
| EXEL | EXELIXIS INC | 1,899,151 | $41.5M | 15.3% | $18.49 | +13.1% | — | 30161Q104 |
| BIIB | BIOGEN INC | 160,480 | $41.24M | 15.2% | $267.94 | -0.2% | — | 09062X103 |
| REGN | REGENERON PHARMACEUTICALS | 47,256 | $38.89M | 14.3% | $342.96 | +127.9% | — | 75886F107 |
| ALKS | ALKERMES PLC | 906,060 | $25.38M | 9.3% | $18.73 | +56.5% | — | G01767105 |
| CAH | CARDINAL HEALTH INC | 291,319 | $25.29M | 9.3% | $56.53 | +53.4% | — | 14149Y108 |
| — | TARO PHARMACEUTICAL INDUS | 640,735 | $24.16M | 8.9% | $70.84 | — | — | M8737E108 |
| EMBC | EMBECTA CORP | 1,164,876 | $17.53M | 6.5% | $24.73 | -31.5% | — | 29082K105 |
| ENTA | ENANTA PHARMACEUTICALS INC | 735,103 | $8.211M | 3.0% | $42.06 | -61.7% | — | 29251M106 |
| EGRX | EAGLE PHARMACEUTICALS INC | 112,666 | $1.777M | 0.7% | $44.36 | -59.5% | — | 269796108 |
| VNDA | VANDA PHARMACEUTICALS INC | 360,429 | $1.557M | 0.6% | $10.33 | -46.2% | — | 921659108 |
| KOD | KODIAK SCIENCES INC | 342,312 | $616K | 0.2% | $33.04 | -89.3% | — | 50015M109 |